Biotechnology Investment fund raises stake in private companies
This article was originally published in Clinica
Executive Summary
Biotechnology Investment Limited (BIL), one of the UK's few investment companies concentrating on development-stage companies in the biotechnology sector, saw its investments in quoted companies fall by 38% in value, to $204 million last year. Its investments in private companies rose, however, by 7%, to $83 million.